弥漫性低级别胶质瘤中基因改变的预后意义
研究基于日本308例低级别胶质瘤(LGG)队列,按IDH突变和1p/19q共缺失分3个亚型,用Cox回归分析各亚型中基因改变与临床病理因素对生存的影响,并在TCGA的414例LGG数据集中验证。结果显示各亚型存在特异的预后相关基因病变,可用于亚型内患者分层。
要点
- 少突胶质细胞瘤、IDH突变且1p/19q共缺失亚型中,NOTCH1突变(P=0.0041)和不完全切除(P=0.0019)与更短生存显著相关。
- 星形细胞瘤、IDH突变亚型中,PIK3R1突变(P=0.0014)和视网膜母细胞瘤通路基因(RB1、CDKN2A、CDK4)改变(P=0.013)是不良生存的独立预测因素。
- IDH野生型LGG中,7p获得、10q缺失、TERT启动子突变(P=0.024)和III级组织学(P<0.0001)共同独立预测不良生存。
核心结论
- 亚型特异性基因病变可用于对每个LGG亚型内的患者进行分层,从而实现更好的预后判断和管理。
研究设计与样本
- 采用Cox比例风险回归模型,在日本308例完全进行驱动突变和拷贝数变异基因分型的LGG病例队列中,研究各亚型中基因改变和临床病理因素对生存的影响。
- 结果在癌症基因组图谱(TCGA)可用的414例LGG数据集中进行验证。
主要发现
- 少突胶质细胞瘤、IDH突变且1p/19q共缺失亚型中,NOTCH1突变(P=0.0041)和不完全切除(P=0.0019)与更短生存显著相关。
- 星形细胞瘤、IDH突变亚型中,PIK3R1突变(P=0.0014)和视网膜母细胞瘤通路基因(RB1、CDKN2A和CDK4)改变(P=0.013)是不良生存的独立预测因素。
- IDH野生型LGG中,7p获得、10q缺失、TERT启动子突变(P=0.024)和III级组织学(P<0.0001)共同独立预测不良生存。
- 无上述任何因素的IDH野生型LGG与其他IDH野生型LGG相比,诊断年龄更小(P=0.042),且较少具有胶质母细胞瘤特征性基因病变,提示其可能代表生物学上不同的亚型。
- 上述结果在TCGA队列中基本得到验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse lower-grade gliomas (LGGs) are genetically classified into 3 distinct subtypes based on isocitrate dehydrogenase (IDH) mutation status and codeletion of chromosome 1p and 19q (1p/19q). However, the subtype-specific effects of additional genetic lesions on survival are largely unknown. METHODS: Using Cox proportional hazards regression modeling, we investigated the subtype-specific effects of genetic alterations and clinicopathological factors on survival in each LGG subtype, in a Japanese cohort of LGG cases fully genotyped for driver mutations and copy number variations associated with LGGs (n = 308). The results were validated using a dataset from 414 LGG cases available from The Cancer Genome Atlas (TCGA). RESULTS: In Oligodendroglioma, IDH-mutant and 1p/19q codeleted, NOTCH1 mutations (P = 0.0041) and incomplete resection (P = 0.0019) were significantly associated with shorter survival. In Astrocytoma, IDH-mutant, PIK3R1 mutations (P = 0.0014) and altered retinoblastoma pathway genes (RB1, CDKN2A, and CDK4) (P = 0.013) were independent predictors of poor survival. In IDH-wildtype LGGs, co-occurrence of 7p gain, 10q loss, mutation in the TERT promoter (P = 0.024), and grade III histology (P < 0.0001) independently predicted poor survival. IDH-wildtype LGGs without any of these factors were diagnosed at a younger age (P = 0.042), and were less likely to have genetic lesions characteristic of glioblastoma, in comparison with other IDH-wildtype LGGs, suggesting that they likely represented biologically different subtypes. These results were largely confirmed in the cohort of TCGA. CONCLUSIONS: Subtype-specific genetic lesions can be used to stratify patients within each LGG subtype. enabling better prognostication and management.
引用
- Aoki K, Nakamura H, Suzuki H, et al. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol. 2018. PMID: 29016839. doi:10.1093/neuonc/nox132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。